Cannabis Bioscience International Holdings Engages StoneBridge Advisory for Comprehensive Company Valuation

Rhea-AI Summary

Cannabis Bioscience International Holdings (CBIH) has engaged StoneBridge Advisory for a comprehensive company valuation. StoneBridge, a Colorado-based firm with over 30 years of experience, specializes in business valuations and mergers and acquisitions. This valuation aims to enhance strategic decision-making, attract investments, and facilitate negotiations, especially in light of potential U.S. federal reclassification of cannabis.

CBIH anticipates the valuation will help identify growth opportunities and navigate the evolving medical cannabis market. The company is preparing to capitalize on new business partnerships, funding, and banking services stemming from possible legal changes. The valuation is seen as essential for market comparison and long-term sustainability.

Positive

• Engagement of StoneBridge Advisory, a firm with over 30 years of experience.
• Potential to enhance strategic decision-making and attract investment.
• Valuation helps facilitate negotiations and assess merger and acquisition compatibility.
• Preparation for potential legal changes in cannabis reclassification by U.S. government.
• Identification of growth opportunities through comprehensive valuation.

Negative

• No immediate financial benefits or revenue increase mentioned.
• Dependence on future legal changes for potential benefits.
• No concrete figures or financial data provided in the announcement.

Houston, Texas--(Newsfile Corp. - May 29, 2024) - Cannabis Bioscience International Holdings (OTC Pink: CBIH) announces the engagement of StoneBridge Advisory (stonebridgema.com) for CBIH's company valuation. The Colorado-based firm specializes in business valuations as well as mergers and acquisitions, boasting over three decades of experience in the industry. They represent businesses for sale, and their expertise lies in in-depth professional valuation reports that are IRS Revenue Ruling 59-60 compliant, and meet the Uniform Standards of Professional Appraisal Practice.

"As our company continues to evolve and reconstruct itself, we are being approached multiple times per month with potential merger and acquisitions discussions, therefore, having a precise valuation becomes indispensable. It provides useful information to assess compatibility, softens potential disagreements on transaction terms and facilitates negotiations that could benefit all stakeholders" says John Jones, CBIH Treasurer and Director.

From a strategic point of view, a valuation could enhance strategic decision-making, and attract investment. However, it is expected to transcend mere financial metrics, as it helps to identify growth opportunities, and navigate competitive and rapidly changing industries. This applies especially to medical cannabis, as the pending reclassification of the plant by the U.S. government could soon approach.

"This legal rehabilitation of cannabis could unlock new avenues for business partnerships/opportunities, funding, and banking services. Consequently, CBIH is preparing to seize these advantages, ensuring we are equipped to navigate any scenario that could offer substantial benefits to our company and its shareholders," states Viviana Camacho, CBIH Corporate Controller.

CBIH's business program has advanced around multiple edges allowing our valuation to extend beyond traditional financial indicators, acting as a critical framework for assessing our company's worth, pinpointing expansion possibilities, and steering through the dynamic landscape of the medical cannabis market.

There is no doubt that valuation is a tool to foster growth, market comparison for our impending sales process, and ensure long-term sustainability. It is a cornerstone of effective business management, and overall corporate governance which is critical for this period in the life of our company.

FORWARD-LOOKING STATEMENTS
This press release may contain forward-looking statements. The words "believe," "expect," "should," "intend," "estimate," "projects," variations of such words and similar expressions identify forward-looking statements, but their absence does not mean that a statement is not a forward-looking statement. These forward-looking statements are based upon the Company's current expectations and are subject to a number of risks, uncertainties, and assumptions. The Company undertakes no obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise. Among the important factors that could cause actual results to differ significantly from those expressed or implied by such forward-looking statements are risks that are detailed in the Company's filings, which are on file at www.OTCmarkets.com.

For more information contact us at:
(214) 733-0868
ir@cbih.net
Dante Picazo
CEO - CBIH
Website: www.cbih.net
X: www.twitter.com/cbihstock
Instagram: www.instagram.com/CBIHSTOCK

Investor Relations:
East Coast
Peter Nicosia
Bull in Advantage, LLC
Phone: 585-703-6565
Email: Info@BlueHorseshoeStocks.com

West Coast
Zach Logan
Pacific Capital Markets LLC
Phone: 858.864.0011
Email: pacificcapitalmarketsllc@gmail.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/210699

FAQ

What is the purpose of Cannabis Bioscience International Holdings' valuation?

The valuation aims to enhance strategic decision-making, attract investments, and facilitate negotiations for mergers and acquisitions.

Who is conducting the company valuation for CBIH?

StoneBridge Advisory, a Colorado-based firm with over 30 years of experience in business valuations and mergers and acquisitions.

How could U.S. cannabis reclassification impact CBIH?

Reclassification could unlock new business partnerships, funding, and banking opportunities.

What strategic benefits does CBIH seek from the valuation?

The valuation is expected to identify growth opportunities and help navigate the competitive medical cannabis market.

What experience does StoneBridge Advisory bring to CBIH's valuation?

StoneBridge Advisory has over three decades of experience and specializes in professional business valuations compliant with IRS and appraisal standards.